Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest EPS Estimates

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for Laboratory Corp of America Holdings LH for the next year ending December, 2012 is $7.14 per share. LH's trailing-twelve-month ROE is 24.61%. Quest Diagnostics Incorporated DGX is expected to earn $4.84 per share over the next year ending December, 2012. DGX's PEG ratio is 1.21. Covance Inc CVD is likely to earn $3.28 per share in the next year ending December, 2012. CVD's PEG ratio is 1.25. Alere Inc ALR may earn $3.06 per share in the next year ending December, 2012. ALR's trailing-twelve-month revenue is $2.22 billion. Trading Ideas.